Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Up 144.1% in February

Azitra, Inc. (NYSEAMERICAN:AZTR) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 1,990,000 shares, an increase of 144.1% from the January 31st total of 815,400 shares. Currently, 26.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 6,550,000 shares, the days-to-cover ratio is currently 0.3 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Azitra stock. Virtu Financial LLC lifted its position in shares of Azitra, Inc. (NYSEAMERICAN:AZTR) by 196.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 63,180 shares of the company’s stock after buying an additional 41,866 shares during the period. Virtu Financial LLC owned approximately 0.83% of Azitra worth $27,000 as of its most recent SEC filing. 11.16% of the stock is currently owned by institutional investors.

Azitra Price Performance

AZTR stock opened at $0.36 on Friday. Azitra has a 1 year low of $0.23 and a 1 year high of $12.00.

About Azitra

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.